More effective in slowing gastric emptying and controlling postprandial hyperglycaemia compared to long-acting GLP-1 Agonists. Gastrointestinal intolerance e.g., nausea, vomiting, diarrhea, may limit uses. The gene discussed is GCG; the disease is Hyperglycemia.